Clinical Trials Browser

COVID-19, Leukemia, Lymphoma, Multiple Myeloma

NCT04830046 2025-11-26

Covid-19 Vaccine Responsiveness in MM and Waldenstrom

Completed

146 enrolled

LymphoidPlasma cell

COVID-19, Immune System Diseases, Waldenstrom Macroglobulinemia, Multiple Myeloma

NCT05655546 2025-08-08

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Phase NA Terminated

2,117 enrolled 6 charts

LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Graft vs Host Disease, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Multiple Myeloma, Neoplasms, HIV Infections

NCT05831787 2024-06-17

COSMIC

Active not recruiting

200 enrolled

Plasma cell

COVID-19, Multiple Myeloma, Neoplasms, Plasma Cell

NCT04492371 2024-03-05

EMN-COVID

Completed

1,054 enrolled

Plasma cell

COVID-19, Multiple Myeloma, Coronavirus Infections

NCT04805203 2023-10-19

Covimmunomm

Phase NA Terminated

139 enrolled

Plasma cell

COVID-19, Multiple Myeloma

NCT05393999 2023-04-24

SABRE

Phase 2 Withdrawn

LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Leukemia, Lymphoma, Purpura, Thrombotic Thrombocytopenic, Purpura, Thrombocytopenic, Idiopathic, Neoplasms, Plasma Cell

NCT04352556 2022-09-23

COVID19-hematological Malignancies: the Italian Hematology Alliance

Unknown

250 enrolled

LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Leukemia, Lymphoma, Multiple Myeloma, Hematologic Neoplasms

NCT04760184 2022-02-08

AutoCOVID-19

Completed

20 enrolled

LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Lymphoma, Multiple Myeloma, Hematologic Neoplasms

Clinical Trials

SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

Covid-19 Vaccine Responsiveness in MM and Waldenstrom

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

COSMIC

EMN-COVID

Covimmunomm

SABRE

COVID19-hematological Malignancies: the Italian Hematology Alliance

AutoCOVID-19